Shuo Liu

Dr. Shuo Liu


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
RLRunyuan Liu
Runyuan Liu
SLShuo Liu
Shuo Liu
SWSaixuan Wu
Saixuan Wu
MXMeng Xia
Meng Xia
WLWanqing Liu
Wanqing Liu
WNWeidong Niu
Weidong Niu
Chronic apical periodontitis (CAP) is a disease with characteristics of inflammation and bone loss. In this study, our objective was to examine the function of small extracellular vesicles (sEVs) obtained from milk in encouraging osteogenic differentiation and inhibiting inflammation by miR-21 in CAP. The expression of miR-21 was detected using qRT-PCR in human CAP samples. The impact of miR-21 on the process of osteogenic differentiation was investigated using CCK-8, qRT-PCR, immunofluorescence staining, and Western blot analysis. The evaluation of RAW 264.7 cell polarization and the assessment of inflammatory factor expression were conducted through qRT-PCR. The influence of sEVs on MC3T3-E1 cells and RAW 264.7 cells was examined, with a particular emphasis on the involvement of miR-21. In human CAP samples, a decrease in miR-21 expression was observed. MiR-21 increased the expression of osteogenesis-related genes and M2 polarization genes while decreasing the expression of M1 polarization genes and inflammatory cytokines. Treatment with milk-derived sEVs also promoted osteogenesis and M2 polarization while inhibiting M1 polarization and inflammation. Conversely, the addition of miR-21 inhibitors resulted in opposite effects. Our results indicated that sEVs derived from milk had a positive effect on bone formation and activation of anti-inflammatory (M2) macrophages and simultaneously reduced inflammation by regulating miR-21 in CAP.

Verified
Journal Article
Open access
PDF file
CYChen Qian Yang
Chen Qian Yang
YWYuhan Wang
Yuhan Wang
CSChun Shi
Chun Shi
MTMeichen Tong
Meichen Tong
HSHaibo Sun
Haibo Sun
LWLina Wang
Lina Wang
(1) To examine the potential mechanism of the Asarum–Angelica drug pair against periodontitis and provide an experimental basis for the treatment of periodontitis with herbal medicine. (2) The core components and core targets of the Asarum–Angelica drug pair in the treatment of periodontitis were detected according to network pharmacology methods. Finally, the effect of the Asarum–Angelica drug pair on osteogenic differentiation was observed in mouse embryonic osteoblast precursor cells. (3) According to the results of network pharmacology, there are 10 potential active ingredients in the Asarum–Angelica drug pair, and 44 potential targets were obtained by mapping the targets with periodontitis treatment. Ten potential active ingredients, such as kaempferol and β-sitosterol, may play a role in treating periodontitis. Cell experiments showed that the Asarum–Angelica drug pair can effectively promote the expression of osteoblast markers alkaline phosphatase (ALP), Runt-related Transcription Factor 2 (RUNX2), and BCL2 mRNA and protein in an inflammatory environment (p < 0.05). (4) Network pharmacology effectively analyzed the molecular mechanism of Asarum–Angelica in the treatment of periodontitis, and the Asarum–Angelica drug pair can promote the differentiation of osteoblasts.

6 July 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RWRuyue Wang
Ruyue Wang
JHJinyue Hu
Jinyue Hu
QSQing Sun
Qing Sun
SGShuixiang Guo
Shuixiang Guo
GZGege Zhang
Gege Zhang
LWLina Wang
Lina Wang
Periodontitis is a chronic inflammatory disease that mainly occurs in the dental supporting tissues. Endoplasmic reticulum autophagy (ER-phagy) is a new type of selective autophagy. The main function of ER-phagy is to degrade excess ER membranes or toxic protein aggregates, control the volume of ER, and maintain cell homeostasis. This study utilized bioinformatics to identify and validate potential ER-phagy-related biomarkers for periodontitis. The relationship between immune cell infiltration and periodontitis as well as potential biomarkers was analyzed, to identify new targets for the diagnosis and treatment of periodontitis. Data from GeneCards and Gene Expression Omnibus (GEO) databases were utilized to identify differentially-expressed ER-phagy-related genes, and to conduct functional enrichment and pathway analyses. Random forest, least absolute shrinkage and selection operator (LASSO) and support vector machine-recursive feature removal (SVM-RFE) algorithms were used to identify hub genes. Receiver operating characteristic (ROC) curves and areas under the curve (AUCs) were calculated to assess diagnostic performance and identify potential biomarkers for periodontitis. The CIBERSORT deconvolution algorithm was used to study the link between potential biomarkers and distinct types of immune cells. In addition, clinical samples were examined using Real-time quantitative polymerase chain reaction (RT-qPCR) to verify the expression of genes related to ER-phagy in periodontitis and identify a signature which may better predict this disease. Bioinformatics analysis identified 88 differentially-expressed ER-phagy-related genes (DE-ERGs). 6 hub genes were found using LASSO, SVM-RFE and Random forest, namely ATP1A1, CD69, DNAJB11, GANAB, IL7, and PSME2. ATP1A1 and GANAB exhibited robust diagnostic efficacy in both the training set and validation set. The results of immune cell infiltration analysis revealed a significantly greater abundance of plasma cells in periodontitis tissue samples compared to healthy periodontal tissue samples (P < 0.05). Correlation analysis between potential biomarkers and immune cells demonstrated that the expression levels of ATP1A1 and GANAB were correlated with plasma cells and resting dendritic cells. Clinical samples examined by RT-qPCR verified that these ER-phagy-related signature genes in periodontitis may better predict the development of periodontitis.ER-phagy is closely related to the pathological process of periodontitis. The infiltration of immune cells differs between tissues affected by periodontitis and healthy periodontal tissues, and a variety of immune cell subsets are significantly correlated with ATP1A1 and GANAB, thus ATP1A1 and GANAB have good diagnostic efficiency for periodontitis and can be used as potential biomarkers for early diagnosis.

11 September 2025 in Phytomedicine
Verified
Journal Article
Open access
MDMing Dong
Ming Dong
SLShuo Liu
Shuo Liu
HSHaibo Sun
Haibo Sun
MTMeichen Tong
Meichen Tong
QCQianyang Chen
Qianyang Chen
WNWeidong Niu
Weidong Niu
Periodontitis is the number one cause of adult tooth loss worldwide. The main treatments for periodontitis are removed tartar, surgery, and medication, but none of them can bring about a cure. Traditional Chinese medicine as an adjunct to modulation of the host immune response in the treatment of periodontitis needs to be further researched and explored. This study investigated the effect of Hmong Medicine Tooth-fixing Formula (HM-TF) on periosteal bone repair in vivo and in vitro to provide an experimental basis for the use of the Hmong medicine in the clinical treatment of periodontitis. Screening of HM-TF and periodontitis co-action targets by network pharmacology analysis. The effects of HM-TF on the proliferation and differentiation of osteoblasts and osteoclasts were investigated by CCK-8 assay, Real-time qPCR, western blotting, ALP, alizarin red S, and TRAP staining. A rat periodontitis model was established, and micro-computed tomography (CT) and hematoxylin and eosin (HE) staining experiments were carried out to study the effect of HM-TF on bone repair and investigate its biosafety. The core active ingredients of HM-TF for treating periodontitis include quercetin, luteolin, kaempferol, etc. One of the main targets of HM-TF in periodontitis is RXRα, and all the active ingredients can effectively bind to RXRα. HM-TF enhanced the growth of osteoblasts by increasing the production of RXRα and factors related to bone formation. Additionally, it hindered the development of osteoclasts by reducing the expression of factors related to osteoclasts. Three-dimensional (3D) micro-CT, HE staining and immunohistochemical staining showed that HM-TF ameliorated the alveolar bone destruction caused by periodontitis in rats, and the effect was better than that of metronidazole. One of the main intersecting targets of HM-TF and periodontitis is RXRα. HM-TF promoted bone repair in rats with periodontitis and had good biocompatibility.

8 October 2025 in International Journal of Biological Macromolecules
Verified
Journal Article
Open access
SGShuiXiang Guo
ShuiXiang Guo
GZGeGe Zhang
GeGe Zhang
ALAo Lu
Ao Lu
QCQianYang Chen
QianYang Chen
QQQiYu Qu
QiYu Qu
LWLina Wang
Lina Wang
Periodontitis induce alveolar bone destruction, which may result in tooth loosening, exfoliation, or oral functional impairment in severe cases. The development of novel therapeutic agents with sustained efficacy and robust mechanical properties represents a critical unmet need for clinical management of bone defect-related diseases. We investigated the efficacy of Radix Dipsaci (RD), a traditional Chinese medicinal herb, and its derivatives in bone defect therapy by incorporating RD into a nanocomposite hydrogel composed of gelatin methacryloyl (GelMA) and silicate nanoplatelets (SN), yielding an RD-loaded nanocomposite hydrogel (GelMA-SN-RD). The engineered hydrogel exhibited prolonged degradation kinetics, enhanced mechanical properties, and sustained, gradual release of RD bioactive components. GelMA-SN-RD hydrogel significantly upregulated the expression of osteogenesis-related genes and proteins in both physiological and inflammatory microenvironments. In vitro studies using MC3T3-E1 osteoblasts revealed that GelMA-SN-RD hydrogel possessed excellent biocompatibility, significantly increased alkaline phosphatase activity, upregulated osteogenic gene/protein expression, and promoted extracellular matrix mineralization. Moreover, we were delighted to discover that RD endowed the GelMA-SN-RD hydrogel with outstanding activity against Porphyromonas gingivalis. In vivo evaluation in a rat periodontitis model via micro-computed tomography (micro-CT) and immunohistochemical analysis further validated the hydrogel's superior bone regenerative capacity and anti-inflammatory effects, as evidenced by enhanced new bone formation and reduced inflammatory cell infiltration. Collectively, these findings highlight the promising potential of GelMA-SN-RD nanocomposite hydrogel as a dual-function biomaterial for bone tissue engineering applications, integrating mechanical support, controlled drug release, osteogenic induction, antibacterial and anti-inflammatory activity.

29 June 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MDMing Dong
Ming Dong
XYXinxin Yu
Xinxin Yu
SLShuo Liu
Shuo Liu
YHYue Han
Yue Han
WHWenqing Han
Wenqing Han
WNWeidong Niu
Weidong Niu
Objective: Icariin (ICA) is an active small molecule extracted from Epimedium, possessing therapeutic potential for inflammatory bone destruction. Small extracellular vesicles (MEVs) derived from bovine milk are safe and efficient drug delivery carriers. We aimed to explore the potential of ICA-loaded bovine milk EVs (ICA-MEVs) to repair inflammatory bone defects in an inflammatory microenvironment and investigated the underlying molecular mechanism, providing new ideas for the treatment of inflammatory bone defects. Methods: We fabricated icariin (ICA)-loaded milk-derived extracellular vesicles (ICA-MEVs) embedded in GelMA hydrogel and systematically evaluated the in vivo repairing efficacy against lipopolysaccharide (LPS)-induced inflammatory calvarial bone defects via micro-CT, HE staining, Masson staining and immunohistochemistry. Subsequent in vitro cellular experiments were carried out to uncover the regulatory mechanism by which ICA-MEVs promotes LPS-inhibited osteoblast proliferation and osteogenic differentiation. Results: ICA-MEVs significantly promoted the repair of inflammatory bone defects, upregulated osteogenic factors such as BMP-2, OCN, and Runx-2, and reduced the levels of IL-1β and TNF-α. ICA-loaded MEVs facilitated the proliferation and osteogenic differentiation of MC3T3-E1 osteoblasts while alleviating cellular inflammatory activation. Mechanistically, ICA-MEVs promoted bone repair by elevating LIM1 expression. Elevated LIM1 bound to the endogenous HIF-1α promoter and triggered subsequent transcriptional activation of HIF-1α. Conclusions: Under inflammatory conditions, ICA-MEVs effectively promoted the proliferation and differentiation of MC3T3-E1 cells and inhibited the expression of inflammatory factors. Mechanistically, ICA-MEVs upregulated HIF-1α transcription and expression by potentiating the LIM1-mediated transcriptional activation of the HIF-1α promoter, thereby facilitating inflammatory bone repair. Although milk-derived EVs exhibited favorable safety profiles in this preclinical study, comprehensive detection of immunogenicity and long-term adverse reactions will be necessary in follow-up research to support clinical transformation.